Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say

Starboard Value Might Have Plans To Help Pfizer After $1 Billion Dollar Stake - RetailWire

Starboard Value has reportedly managed to attain a $1 billion stake in Pfizer and revealed plans to reverse the decline of the pharmaceutical company's recent efforts.

Activist Starboard Takes $1 Billion Stake In Pfizer, Seeks Former Execs' Support: Reports

Starboard has reached out to former Pfizer CEO Ian Read and ex-finance chief Frank D'Amelio, and both have expressed interest in supporting the activist investor's turnaround efforts, reports said.

Activist Starboard Value Takes $1 Billion Stake in Pfizer

Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer Inc. and is seeking to spur a turnaround of the struggling pharmaceuticals giant, according to a person familiar with the matter.

Activist investor Starboard Value takes $1 bln stake in Pfizer, sources say

Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make changes to turn its performance around, sources familiar with the matter said on Sunday.

Activist investor Starboard has informed Pfizer it has taken a stake

An activist investor has taken a stake in Pfizer.Kamil Krzaczynski/AFP via Getty ImagesStarboard Value has taken a stake in Pfizer, people familiar with the matter said.The drug giant's stock price has dropped significantly since its COVID-19 vaccine rollout.Starboard's stake in Pfizer is reportedly worth about $1 billion.Starboard Value has its next target: pharma giant Pfizer.The activist investor has informed Pfizer that it has taken a signif…

Activist Starboard Reportedly Takes Billion Dollar Stake In Pfizer To Right Sinking Ship  - Nemos News Network

Pfizer shares are up in premarket trading in New York after a report from the Wall Street Journal revealed that activist investor Starboard Value has taken a $1 billion stake in the struggling pharmaceutical giant, aiming for a major turnaround. Pfizer’s stock had skyrocketed during the pandemic, driven by new Covid vaccine sales, but with the […]